Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Fischer, S. and Zechmeister-Koss, I. (2012): Radiofrequency Ablation for the Treatment of Head and Neck Cancer. Decision Support Document 55.

Rothschedl, E. and Grössmann, N. (2024): Toripalimab (Loqtorzi®) in combination with cisplatin and gemcitabine for the first-line treatment of recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC). Fact Sheet Nr. 184.

Rothschedl, E. and Wolf, S. (2025): Tislelizumab (Tevimbra®) in combination with gemcitabine and cisplatin for the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma. Fact Sheet Nr. 233.

Wild, C. (2003): [Endoscopic sinus surgery for nasal polyps]. HTA-Newsletter 22: pp. 3-4.